These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8738483

  • 21. Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.
    Kim E, Sohn S, Lee M, Park C, Jung J, Park S.
    Pituitary; 2005; 8(2):155-62. PubMed ID: 16379030
    [Abstract] [Full Text] [Related]

  • 22. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S, Ballaré E, Mantovani G, Lania A, Losa M, Di Blasio AM, Spada A.
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [Abstract] [Full Text] [Related]

  • 23. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
    Lania A, Mantovani G, Ferrante E, Zavanone LM, Locatelli M, Corbetta S, Beck-Peccoz P, Spada A.
    J Endocrinol Invest; 2004 Apr; 27(4):328-33. PubMed ID: 15233551
    [Abstract] [Full Text] [Related]

  • 24. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein.
    Kim K, Sanno N, Arai K, Takano K, Yasufuku-Takano J, Teramoto A, Shibasaki T.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888
    [Abstract] [Full Text] [Related]

  • 25. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity.
    Barlier A, Pellegrini-Bouiller I, Gunz G, Zamora AJ, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2759-65. PubMed ID: 10443675
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
    Faccenda E, Melmed S, Bevan JS, Eidne KA.
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
    [Abstract] [Full Text] [Related]

  • 30. Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma.
    Wakabayashi I, Inokuchi K, Hasegawa O, Sugihara H, Minami S.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):357-61. PubMed ID: 1730814
    [Abstract] [Full Text] [Related]

  • 31. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
    Faglia G, Arosio M, Spada A.
    Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
    [Abstract] [Full Text] [Related]

  • 32. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
    Peri A, Conforti B, Baglioni-Peri S, Luciani P, Cioppi F, Buci L, Corbetta S, Ballaré E, Serio M, Spada A.
    J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
    Mendoza V, Sosa E, Espinosa-de-Los-Monteros AL, Salcedo M, Guinto G, Cheng S, Sandoval C, Mercado M.
    Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569
    [Abstract] [Full Text] [Related]

  • 35. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K, Takano K, Yasufuku-Takano J, Yamada S, Teramoto A, Takei M, Osamura RY, Sano T, Fujita T.
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [Abstract] [Full Text] [Related]

  • 36. Clinical and biochemical characteristics of growth hormone-secreting pituitary tumors.
    Bai X, Lei T, Liu K.
    J Tongji Med Univ; 2000 Mar; 20(3):212-3. PubMed ID: 11215051
    [Abstract] [Full Text] [Related]

  • 37. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
    Wilson DM, Hoffman AR.
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
    [Abstract] [Full Text] [Related]

  • 38. Preliminary study on the relationship between cAMP level and gsp expression in cultured human pituitary somatotrophinomas.
    Lei T, Liu Q, Li L, Zhang L, Shu K, Xue D.
    J Tongji Med Univ; 2000 Sep; 20(3):214-6. PubMed ID: 11215052
    [Abstract] [Full Text] [Related]

  • 39. Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas.
    Lei T, Adams EF, Buchfelder M, Fahlbusch R.
    Neurosurgery; 1996 Sep; 39(3):569-75; discussion 575-6. PubMed ID: 8875488
    [Abstract] [Full Text] [Related]

  • 40. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW, Verleun T, Oosterom R.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.